Lisa Horvath

Lisa Horvath is the inaugural Director of Research at Chris O’Brien Lifehouse. Prior to heading up the research department, Lisa was the Director of Medical Oncology at Royal Prince Alfred Hospital for seven years before transitioning the service to Chris O’Brien Lifehouse where she remained at the helm for another seven years.

Lisa is the conjoint Professor of Medical Oncology (Genitourinary cancer) at the University of Sydney. She is also a member of Faculty at the Garvan Institute of Medical Research and Head of Advanced Prostate Cancer research group.

As a clinician scientist, Lisa has published more than 130 original research papers in peer-reviewed journals in the last 20 years. These papers range across the areas of clinical science, clinical trials research and translation into clinical practice. She has presented extensively at national and international meetings both peer-reviewed and invited presentations.

Her research interest is predominantly in the field of prostate cancer, especially drug resistance in castrate-resistant prostate cancer and she is involved with numerous clinical trials in prostate cancer as well as Phase 1 testing of new therapeutics.

Lisa was awarded a $1.9 million grant from the National Health and Medical Research Council Investigator Grant in 2020. This was for her internationally recognised prostate cancer research into how biomarkers in the blood can be used to personalise and hone treatment for men with advanced prostate cancer, potentially leading to the development of more effective, personalised treatments for patients in the future.